Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,853,769
+$3,785,624 QoQ
Shares Held
2,025,526
+57.7% QoQ
Ownership
3.19%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
16 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. MGNX ranks #90 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,099,318 | $363,731,344 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
317,058 | $141,579,078 | |
| 3 | INCY |
Incyte Corp
|
1,253,138 | $117,945,347 | |
| 4 | RPRX |
Royalty Pharma plc
|
2,120,692 | $101,729,594 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
3,761,437 | $81,247,039 | |
| 6 | PTGX |
Protagonist Therapeutics, Inc
|
628,075 | $66,199,104 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
2,246,943 | $62,240,320 | |
| 8 | COGT |
Cogent Biosciences, Inc.
|
1,600,168 | $61,590,466 |
All Filings in MGNX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,853,769 | 2,025,526 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $2,068,145 | 1,284,563 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,057,618 | 629,535 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $491,151 | 405,911 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $379,764 | 299,028 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $1,279,739 | 393,766 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $1,255,186 | 381,516 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $2,796,529 | 658,007 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $541,328 | 36,775 | Shares | Other | 2024-05-15 | |
| 2023-06-30 | $459,185 | 85,829 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $1,849,487 | 257,948 | Shares | Other | 2023-05-15 | |
| 2022-09-30 | $824,514 | 238,299 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $2,050,084 | 694,944 | Shares | Other | 2022-08-15 | |
| 2021-09-30 | $419,867 | 20,051 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $871,491 | 38,123 | Shares | Sole | 2021-02-16 | |
| 2020-03-31 | $369,430 | 63,476 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||